MENU
+Compare
SCYX
Stock ticker: NASDAQ
AS OF
Aug 7 closing price
Price
$0.88
Change
+$0.17 (+23.94%)
Capitalization
55.88M

SCYX SCYNEXIS Forecast, Technical & Fundamental Analysis

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SCYX with price predictions
Aug 07, 2025

Momentum Indicator for SCYX turns positive, indicating new upward trend

SCYX saw its Momentum Indicator move above the 0 level on August 07, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where SCYX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCYX just turned positive on August 05, 2025. Looking at past instances where SCYX's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

SCYX moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCYX advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCYX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SCYX broke above its upper Bollinger Band on August 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SCYX entered a downward trend on July 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.766) is normal, around the industry mean (64.082). P/E Ratio (1.065) is within average values for comparable stocks, (89.433). SCYX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.511) is also within normal values, averaging (18.681).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SCYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SCYX is expected to report earnings to rise 78.82% to -19 cents per share on August 18

SCYNEXIS SCYX Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.08
Q2'24
Missed
by $0.15
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -20 cents. With 978.92K shares outstanding, the current market capitalization sits at 55.88M.
A.I. Advisor
published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
36
Web
https://www.scynexis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIMEF0.820.04
+4.98%
CIMC Enric Holdings Ltd.
CFNB18.95N/A
N/A
California First Leasing Corporation
MZTFF34.68N/A
N/A
Mizrahi Tefahot Bank Ltd.
AILLN78.30N/A
N/A
Ameren Illinois Company
NFLDF0.03N/A
-0.88%
Exploits Discovery Corp.

SCYX and Stocks

Correlation & Price change

A.I.dvisor tells us that SCYX and AQST have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+23.41%
AQST - SCYX
33%
Poorly correlated
-1.50%
TLRY - SCYX
30%
Poorly correlated
+5.40%
AKAN - SCYX
29%
Poorly correlated
+20.56%
CRDL - SCYX
28%
Poorly correlated
+1.40%
ACET - SCYX
27%
Poorly correlated
-1.97%
More